Drive Therapeutics
PrivateLast Round
Series A
Jul 1, 2026
Total Funding Raised
$1.42M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Drive Therapeutics operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Grant round in July 2025.
Drive Therapeutics is a biotechnology company that develops bispecific aptamer therapeutics for the treatment of retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Drive Therapeutics Comparables
Compare Drive Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ribomic Inc. | 79% | |
| Roche Holding | 69% | |
| Kodiak Sciences Inc. | 69% |
For institutional investors. Book with your work email.
Drive Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2026 | ||||
| Grant | Jul 15, 2025 | ||||
| Debt | Sep 30, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
| Debt | Nov 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Drive Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| First Flight Venture Center | Debt |
| North Carolina Biotechnology Center | Debt |
| One North Carolina Small Business Program | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 724% MoM.
- Jul 7, 2025
Monthly visitors increased 725% MoM.
For institutional investors. Book with your work email.
Drive Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Drive Therapeutics's valuation, stock price, and market status.
Is Drive Therapeutics a public or private company?
Drive Therapeutics is a private company.
What is the current stock price of Drive Therapeutics?
Drive Therapeutics is a private company, so its shares have no public market price. Caplight tracks Drive Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Drive Therapeutics worth (valuation)?
Valuation information for Drive Therapeutics is not publicly available.
Can I buy Drive Therapeutics stock?
Drive Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Drive Therapeutics's last funding round?
Drive Therapeutics's most recent funding round was Series A on July 1, 2026.
Who are the main investors in Drive Therapeutics?
Key investors in Drive Therapeutics include First Flight Venture Center, North Carolina Biotechnology Center, One North Carolina Small Business Program, National Science Foundation.
Will Drive Therapeutics IPO soon?
No public IPO plans have been announced for Drive Therapeutics.
How can I track Drive Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Drive Therapeutics's shares on secondary markets.